[Pharmacokinetic studies on 14C-azapropazone dihydrate in man].
D000284:Administration, Oral; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism*; D002214:Capsules; D002250:Carbon Radioisotopes; D004123:Dimethylamines / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D005780:Gelatin; D006207:Half-Life; D006801:Humans; D007408:Intestinal Absorption; D008297:Male; D008314:Malonates / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism; D013997:Time Factors; D014227:Triazines / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism*
D000893:Anti-Inflammatory Agents; D002214:Capsules; D002250:Carbon Radioisotopes; D004123:Dimethylamines; D008314:Malonates; D014227:Triazines; D005780:Gelatin
Humanpharmakokinetische Untersuchungen mit 14C-Azapropazon-Dihydrat.